Institute of Communications and Computer Systems, Athens, Greece
SINGULARLOGIC
NHG CONSULTING OY
Noona Healthcare
Age
18–70
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Presence of a devoted informed consent signed by the patient and the physician
Histologically confirmed invasive early or locally advanced operable breast cancer
Tumour stage I, II and III
Patients receiving surgery as part of the local treatment
Patients receiving any type of systemic treatment regardless of treatment type and/or adjuvant radiation therapy if indicated as part of the local treatment
You may not be if
Refusal to sign informed consent
Presence of distant metastases
History of another malignancy or contralateral invasive breast cancer within the last five years except cured basal cell carcinoma of skin or carcinoma in situ of the uterine cervix
History of early onset (i.e., before 40 years of age) mental disorder (i.e., schizophrenia, psychosis, bipolar disorder, diagnosis of major depression) or severe neurologic disorder (i.e., neurodegenerative disorder, dementia)
Serious other diagnosed concomitant diseases such as clinically significant (i.e. active) cardiac disease (e.g. congestive heart failure, symptomatic coronary artery disease or cardiac arrhythmia not well controlled with medication) or myocardial infarction within the last 12 months.
Major surgery for a severe disease or trauma which could affect patient's psychosocial wellbeing (for example, major heart or abdominal surgery) within 4 weeks prior to study entry or lack of complete recovery from the effects of surgery
Treatment for invasive cancer
Treatment for any major illness in the last half year
Pregnancy or breastfeeding at time of recruitment
Clareo Health | Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back
